FEDELE, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 611
EU - Europa 265
AS - Asia 100
AF - Africa 12
Totale 988
Nazione #
US - Stati Uniti d'America 601
IT - Italia 58
SE - Svezia 51
CN - Cina 49
UA - Ucraina 48
NL - Olanda 46
SG - Singapore 42
IE - Irlanda 22
FI - Finlandia 17
CI - Costa d'Avorio 12
DE - Germania 11
GB - Regno Unito 11
CA - Canada 10
IN - India 4
VN - Vietnam 4
FR - Francia 1
JP - Giappone 1
Totale 988
Città #
Chandler 180
Jacksonville 49
Ashburn 48
Amsterdam 44
Ann Arbor 30
Singapore 30
Houston 28
Woodbridge 26
Princeton 19
Beijing 17
Millbury 14
Nanjing 13
Ottawa 10
Wilmington 10
Napoli 9
Des Moines 8
Washington 8
Naples 7
Jiaxing 6
Boardman 5
Boston 5
Dong Ket 4
Nanchang 4
Santa Clara 4
Aversa 3
Hebei 3
Lawrence 3
Caserta 2
Dublin 2
Los Angeles 2
Norwalk 2
Pune 2
Tianjin 2
Torino 2
Bangalore 1
Buffalo 1
Calvizzano 1
Clifton 1
Cormeilles-en-Parisis 1
Falls Church 1
Guangzhou 1
Hangzhou 1
Helsinki 1
Indiana 1
Kronberg 1
Milan 1
Monmouth Junction 1
Montalto Dora 1
Mountain View 1
New York 1
Oderzo 1
Orange 1
Padova 1
Pozzuoli 1
San Francisco 1
San Mateo 1
Shanghai 1
Sheffield 1
Shenyang 1
Tappahannock 1
Thiene 1
Tokyo 1
Yellow Springs 1
Totale 630
Nome #
Phosphorylation of high-mobility group protein A2 by Nek2 kinase during the first meiotic division in mouse spermatocytes. 72
HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity 69
HMGA1 protein expression sensitizes cells to cisplatin-induced cell death. 67
HMGA1 protein overexpression in human breast carcinomas: correlation with ErbB2 expression. 67
IFN-gamma gene expression is controlled by the architectural transcription factor HMGA1. 60
Identification of the genes up- and down-regulated by the high mobility group A1 (HMGA1) proteins: tissue specificity of the HMGA1-dependent gene regulation. 58
PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration 55
High-mobility-group A1 (HMGA1) proteins down-regulate the expression of the recombination activating gene 2 (RAG2). 53
Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas. 52
PATZ1 is a target of miR-29b that is induced by Ha-Ras oncogene in rat thyroid cells 51
Roles of HMGA proteins in cancer. 47
Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice 45
CBX7 is a tumor suppressor in mice and humans. 42
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer 41
Loss of one or two PATZ1 alleles has a critical role in the progression of thyroid carcinomas induced by the RET/PTC1 oncogene 38
Dual oncogenic/anti-oncogenic role of PATZ1 in FRTL5 rat thyroid cells transformed by the Ha-Ras v12 oncogene 36
PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype 34
HMGA2 cooperates with either p27kip1deficiency or Cdk4R24Cmutation in pituitary tumorigenesis 32
Complementary actions of dopamine D2 receptor agonist and anti-vegf therapy on tumoral vessel normalization in a transgenic mouse model 29
Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice. 27
CBX7 gene expression plays a negative role in adipocyte cell growth and differentiation 26
The Genetics of Pituitary Adenomas 21
null 11
Totale 1.033
Categoria #
all - tutte 3.827
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.827


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202099 29 0 10 2 12 0 0 8 0 4 22 12
2020/2021147 0 9 25 10 10 22 11 1 16 17 17 9
2021/2022125 5 0 0 1 0 4 2 2 21 16 38 36
2022/2023320 30 41 6 51 27 44 0 28 37 44 8 4
2023/2024131 4 17 11 16 12 21 10 13 0 2 21 4
2024/202534 34 0 0 0 0 0 0 0 0 0 0 0
Totale 1.033